

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in preventing recurrent stroke | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-1012/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-1012" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in preventing recurrent stroke" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in preventing recurrent stroke.">
            <meta name="og:description" content="Read the latest article version by J David Spence, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="25610">
            <meta name="article-id" content="23199">
            <meta name="dc.title" content="Recent advances in preventing recurrent stroke">
            <meta name="dc.description" content="Since a 2017 update, there have been important advances in stroke prevention. These include new evidence about nutrition, antiplatelet therapy, anticoagulation, lipid-lowering therapy, hypertension control, pioglitazone, and carotid endarterectomy and stenting. Evidence regarding toxic metabolites produced by the intestinal microbiome from egg yolk and red meat has important dietary implications, particularly for patients with impaired renal function, including the elderly. They should avoid egg yolk and red meat and limit the intake of animal flesh. Higher doses of folic acid may be needed for patients with the T allele of MTHFR, so it may not be sufficient to give vitamin B12 (methylcobalamin) alone, even in countries with folate fortification. There is now good evidence that lipid-lowering therapy is even more beneficial in the elderly than in younger patients; we should be using lipid-lowering therapy more intensively, often/usually combining statins with ezetimibe. There is new evidence that lower systolic blood pressure targets are better for most patients, but a subgroup with stiff arteries, a wide pulse pressure, and a diastolic pressure of &amp;lt;60 would be more likely to be harmed than helped by aiming for a systolic target of &amp;lt;120 mmHg. There is a better understanding of how the pharmacological properties of direct-acting oral anticoagulants and the metabolism of antiplatelet agents should inform decisions about the use of these agents. Pioglitazone markedly reduces the risk of stroke, both in diabetics and prediabetics; it should be used more widely. It is now clear that carotid endarterectomy is safer than stenting and that the difference is strongly affected by age. Most patients, and in particular older patients, would be better served by endarterectomy than stenting.">
            <meta name="dc.subject" content="Stroke ">
            <meta name="dc.creator" content="Spence, J David">
            <meta name="dc.date" content="2020/08/20">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.23199.1">
            <meta name="dc.source" content="F1000Research 2020 9:1012">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Stroke ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/08/20">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="1012">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.23199.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-1012">
            <meta name="citation_title" content="Recent advances in preventing recurrent stroke">
            <meta name="citation_abstract" content="Since a 2017 update, there have been important advances in stroke prevention. These include new evidence about nutrition, antiplatelet therapy, anticoagulation, lipid-lowering therapy, hypertension control, pioglitazone, and carotid endarterectomy and stenting. Evidence regarding toxic metabolites produced by the intestinal microbiome from egg yolk and red meat has important dietary implications, particularly for patients with impaired renal function, including the elderly. They should avoid egg yolk and red meat and limit the intake of animal flesh. Higher doses of folic acid may be needed for patients with the T allele of MTHFR, so it may not be sufficient to give vitamin B12 (methylcobalamin) alone, even in countries with folate fortification. There is now good evidence that lipid-lowering therapy is even more beneficial in the elderly than in younger patients; we should be using lipid-lowering therapy more intensively, often/usually combining statins with ezetimibe. There is new evidence that lower systolic blood pressure targets are better for most patients, but a subgroup with stiff arteries, a wide pulse pressure, and a diastolic pressure of &amp;lt;60 would be more likely to be harmed than helped by aiming for a systolic target of &amp;lt;120 mmHg. There is a better understanding of how the pharmacological properties of direct-acting oral anticoagulants and the metabolism of antiplatelet agents should inform decisions about the use of these agents. Pioglitazone markedly reduces the risk of stroke, both in diabetics and prediabetics; it should be used more widely. It is now clear that carotid endarterectomy is safer than stenting and that the difference is strongly affected by age. Most patients, and in particular older patients, would be better served by endarterectomy than stenting.">
            <meta name="citation_description" content="Since a 2017 update, there have been important advances in stroke prevention. These include new evidence about nutrition, antiplatelet therapy, anticoagulation, lipid-lowering therapy, hypertension control, pioglitazone, and carotid endarterectomy and stenting. Evidence regarding toxic metabolites produced by the intestinal microbiome from egg yolk and red meat has important dietary implications, particularly for patients with impaired renal function, including the elderly. They should avoid egg yolk and red meat and limit the intake of animal flesh. Higher doses of folic acid may be needed for patients with the T allele of MTHFR, so it may not be sufficient to give vitamin B12 (methylcobalamin) alone, even in countries with folate fortification. There is now good evidence that lipid-lowering therapy is even more beneficial in the elderly than in younger patients; we should be using lipid-lowering therapy more intensively, often/usually combining statins with ezetimibe. There is new evidence that lower systolic blood pressure targets are better for most patients, but a subgroup with stiff arteries, a wide pulse pressure, and a diastolic pressure of &amp;lt;60 would be more likely to be harmed than helped by aiming for a systolic target of &amp;lt;120 mmHg. There is a better understanding of how the pharmacological properties of direct-acting oral anticoagulants and the metabolism of antiplatelet agents should inform decisions about the use of these agents. Pioglitazone markedly reduces the risk of stroke, both in diabetics and prediabetics; it should be used more widely. It is now clear that carotid endarterectomy is safer than stenting and that the difference is strongly affected by age. Most patients, and in particular older patients, would be better served by endarterectomy than stenting.">
            <meta name="citation_keywords" content="Stroke ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="J David Spence">
            <meta name="citation_author_institution" content="Western University, and Stroke Prevention &amp; Atherosclerosis Research Centre, Robarts Research Institute, Ontario, Canada">
            <meta name="citation_publication_date" content="2020/08/20">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="1012">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.23199.1">
            <meta name="citation_firstpage" content="1012">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-1012/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-1012.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=25610 /> <input type=hidden id=articleId name=articleId value=23199 /> <input type=hidden id=xmlUrl value="/articles/9-1012/v1/xml"/> <input type=hidden id=xmlFileName value="-9-1012-v1.xml"> <input type=hidden id=article_uuid value=142923ee-cc57-4df1-91ac-3d2e15092dca /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in preventing recurrent stroke"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.23199.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.23199.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-1012"
  },
  "headline": "Recent advances in preventing recurrent stroke",
  "datePublished": "2020-08-20T15:33:09",
  "dateModified": "2020-08-20T15:33:09",
  "author": [
    {
      "@type": "Person",
      "name": "J David Spence"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Since a 2017 update, there have been important advances in stroke prevention. These include new evidence about nutrition, antiplatelet therapy, anticoagulation, lipid-lowering therapy, hypertension control, pioglitazone, and carotid endarterectomy and stenting. Evidence regarding toxic metabolites produced by the intestinal microbiome from egg yolk and red meat has important dietary implications, particularly for patients with impaired renal function, including the elderly. They should avoid egg yolk and red meat and limit the intake of animal flesh. Higher doses of folic acid may be needed for patients with the T allele of MTHFR, so it may not be sufficient to give vitamin B12 (methylcobalamin) alone, even in countries with folate fortification. There is now good evidence that lipid-lowering therapy is even more beneficial in the elderly than in younger patients; we should be using lipid-lowering therapy more intensively, often/usually combining statins with ezetimibe. There is new evidence that lower systolic blood pressure targets are better for most patients, but a subgroup with stiff arteries, a wide pulse pressure, and a diastolic pressure of &amp;lt;60 would be more likely to be harmed than helped by aiming for a systolic target of &amp;lt;120 mmHg. There is a better understanding of how the pharmacological properties of direct-acting oral anticoagulants and the metabolism of antiplatelet agents should inform decisions about the use of these agents. Pioglitazone markedly reduces the risk of stroke, both in diabetics and prediabetics; it should be used more widely. It is now clear that carotid endarterectomy is safer than stenting and that the difference is strongly affected by age. Most patients, and in particular older patients, would be better served by endarterectomy than stenting."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-1012",
            "name": "Recent advances in preventing recurrent stroke"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in preventing recurrent stroke </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=25610 data-id=23199 data-downloads="" data-views="" data-scholar="10.12688/f1000research.23199.1" data-recommended="" data-doi="10.12688/f1000research.23199.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-1012/v1/pdf?article_uuid=142923ee-cc57-4df1-91ac-3d2e15092dca" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-23199-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-23199-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-23199-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Spence JD. Recent advances in preventing recurrent stroke [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):1012 (<a class=new-orange href="https://doi.org/10.12688/f1000research.23199.1" target=_blank>https://doi.org/10.12688/f1000research.23199.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-23199-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=23199 id=track-article-signin-23199 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/23199?target=/articles/9-1012">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=25610 /> <input name=articleId type=hidden value=23199 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in preventing recurrent stroke</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:dspence@robarts.ca" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>J David Spence</span></a><a href="https://orcid.org/0000-0001-7478-1098" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-7478-1098</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:dspence@robarts.ca" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>J David Spence</span></a><a href="http://orcid.org/0000-0001-7478-1098" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-7478-1098</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 20 Aug 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.23199.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Western University, and Stroke Prevention &amp; Atherosclerosis Research Centre, Robarts Research Institute, Ontario, Canada<br/> <p> <div class=margin-bottom> J David Spence <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=74894-69930></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=74893-69931></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23944-69929></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Since a 2017 update, there have been important advances in stroke prevention. These include new evidence about nutrition, antiplatelet therapy, anticoagulation, lipid-lowering therapy, hypertension control, pioglitazone, and carotid endarterectomy and stenting. Evidence regarding toxic metabolites produced by the intestinal microbiome from egg yolk and red meat has important dietary implications, particularly for patients with impaired renal function, including the elderly. They should avoid egg yolk and red meat and limit the intake of animal flesh. Higher doses of folic acid may be needed for patients with the T allele of MTHFR, so it may not be sufficient to give vitamin B12 (methylcobalamin) alone, even in countries with folate fortification. There is now good evidence that lipid-lowering therapy is even more beneficial in the elderly than in younger patients; we should be using lipid-lowering therapy more intensively, often/usually combining statins with ezetimibe. There is new evidence that lower systolic blood pressure targets are better for most patients, but a subgroup with stiff arteries, a wide pulse pressure, and a diastolic pressure of &lt;60 would be more likely to be harmed than helped by aiming for a systolic target of &lt;120 mmHg. There is a better understanding of how the pharmacological properties of direct-acting oral anticoagulants and the metabolism of antiplatelet agents should inform decisions about the use of these agents. Pioglitazone markedly reduces the risk of stroke, both in diabetics and prediabetics; it should be used more widely. It is now clear that carotid endarterectomy is safer than stenting and that the difference is strongly affected by age. Most patients, and in particular older patients, would be better served by endarterectomy than stenting. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Stroke </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> J David Spence (<a href="mailto:dspence@robarts.ca">dspence@robarts.ca</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> J David Spence </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The author is a consultant to Amgen and Orphan Technologies, and an unpaid officer of Vascularis Inc. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Spence JD. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Spence JD. Recent advances in preventing recurrent stroke [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):1012 (<a href="https://doi.org/10.12688/f1000research.23199.1" target=_blank>https://doi.org/10.12688/f1000research.23199.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 20 Aug 2020, <b>9</b>(Faculty Rev):1012 (<a href="https://doi.org/10.12688/f1000research.23199.1" target=_blank>https://doi.org/10.12688/f1000research.23199.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 20 Aug 2020, <b>9</b>(Faculty Rev):1012 (<a href="https://doi.org/10.12688/f1000research.23199.1" target=_blank>https://doi.org/10.12688/f1000research.23199.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d13574e127>Introduction</h2><p class="" id=d13574e130>In a 2017 update<sup><a href="#ref-1">1</a></sup>, I discussed advances in hypertension, nutrition, anticoagulation, antiplatelet therapy, intracranial stenosis, percutaneous closure of patent foramen ovale, and lipid-lowering therapy. Readers are invited to study that review. In this update, I discuss more recent developments in nutrition, hypertension, antiplatelet therapy, anticoagulation, lipid-lowering therapy, carotid endarterectomy (CEA) and carotid artery stenting (CAS). Exercise, smoking cessation, and adherence are also important, but there have been few recent advances in those topics. A report from the Insulin Resistance Intervention in Stroke (IRIS) trial reported a 34% reduction of stroke within 5 years among participants who quit smoking<sup><a href="#ref-2">2</a></sup>. A Swedish study reported important improvements in risk scores, presumed to be a result of improved adherence, among patients with one or more risk factors attending a prevention program who were shown images of their carotid plaque<sup><a href="#ref-3">3</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13574e148>Nutrition</h2><p class="" id=d13574e151>In 2017, I discussed the important advantages of the Mediterranean diet for stroke prevention. Since then, there have been developments regarding the consumption of cholesterol, meat, and eggs and the dietary implications of the interaction between renal function and the intestinal microbiome.</p><div class=section><a name=d13574e154 class=n-a></a><h3 class=section-title>Meat, cholesterol, and egg consumption</h3><p class="" id=d13574e159>Dietary cholesterol increases cardiovascular risk<sup><a href="#ref-4">4</a></sup>, so it seems obvious that, as egg yolk is very high in cholesterol content, the consumption of eggs would increase cardiovascular risk. Similarly, the consumption of meat, which is high in cholesterol and saturated fat, should also increase cardiovascular risk. This has been difficult to demonstrate, and indeed some observational studies suggest that egg and meat consumption are not harmful. Such findings are very likely based on indication bias and both measured and unmeasured confounders<sup><a href="#ref-5">5</a></sup> and are not biologically plausible. The reason it has been hard to demonstrate harm from eggs and meat is that the US diet is so bad that the AHA reported in 2015 that only 0.1% of Americans consume a healthy diet<sup><a href="#ref-6">6</a></sup>. On that background, it is hard to show that <i>anything</i> makes it worse. On the other hand, in Greece, where the Mediterranean diet is the norm, the harm from egg consumption was more obvious. Among Greek diabetics, an egg a day increased coronary risk fivefold, and even 10 grams/day of egg (a sixth of a large egg) increased coronary risk by 54%<sup><a href="#ref-7">7</a></sup>.</p><p class="" id=d13574e181>Furthermore, besides cholesterol, egg yolk and red meat also contain high levels of dietary precursors of trimethylamine N-oxide (TMAO). High levels of TMAO strongly predicted the 3-year risk of stroke/myocardial infarction/vascular death among &gt;4,000 patients referred to the Cleveland Clinic for coronary angiography<sup><a href="#ref-8">8</a></sup>. We reported in 2018 that plasma levels of TMAO and three other toxic metabolites produced by the intestinal microbiome were significantly higher in patients with severe atherosclerosis not predicted by risk factors (“unexplained atherosclerosis”) than in patients with a protected phenotype (little or no carotid plaque despite high levels of coronary risk factors)<sup><a href="#ref-9">9</a></sup>. Hazen’s group recently reported that phenylacetylglutamine increases cardiovascular risk via effects on adrenergic receptors<sup><a href="#ref-10">10</a></sup>.</p><p class="" id=d13574e196>I recently reviewed evidence that vegetarian diets reduce cardiovascular risk. Perhaps the best evidence about this issue is presented by Zhong <i>et al</i>.<sup><a href="#ref-11">11</a></sup>, who reported that, in the US, on the basis of data from 29,615 participants during a median follow-up of 17.5 years, both cholesterol consumption and egg consumption increased cardiovascular risk in a dose-dependent manner.</p></div><div class=section><a name=d13574e207 class=n-a></a><h3 class=section-title>Interaction of renal function and toxic metabolites of the intestinal microbiome</h3><p class="" id=d13574e212>Plasma levels not only of TMAO but also all of the toxic metabolites of the intestinal microbiome that we measured (TMAO, p-cresyl sulfate, hippuric acid, p-cresyl glucuronide, phenylacetylglutamine, and phenylsulfate), were significantly higher among study participants with an estimated glomerular filtration rate (eGFR) of &lt;66 mL/minute/1.73 m<sup>2</sup><sup><a href="#ref-12">12</a></sup>. Such levels of eGFR are the norm for patients aged over 75<sup><a href="#ref-13">13</a></sup>. This means that patients with impaired renal function, including the elderly, should avoid egg yolk and red meat and limit their intake of animal flesh.</p></div><div class=section><a name=d13574e226 class=n-a></a><h3 class=section-title>B vitamins for lowering of homocysteine</h3><p class="" id=d13574e231>In the previous review<sup><a href="#ref-1">1</a></sup>, I summarized evidence showing that B vitamins to lower homocysteine do indeed reduce the risk of stroke. In the early studies, harm from cyanocobalamin among participants with renal failure obscured the benefit. For that reason, we should use methylcobalamin instead of cyanocobalamin<sup><a href="#ref-14">14</a></sup>. I had been under the impression that folate fortification of the grain supply in North America meant that we needed to give only B12 supplements to reduce the risk of stroke. However, recent studies indicate that patients with the T allele of methylene tetrahydrofolate reductase (MTHFR) probably need higher doses of folate than would be obtained from fortification of the grain supply<sup><a href="#ref-15">15</a></sup>. This means that we will need to reconsider higher doses of folic acid in addition to B12 supplements and perhaps vitamin B6 and riboflavin<sup><a href="#ref-16">16</a>,<a href="#ref-17">17</a></sup> as well. Further study is needed; a trial of methylcobalamin plus folic acid (and perhaps pyridoxine) versus placebo would be important though unlikely to be funded. Subgroups of patients most likely to benefit would be those with metabolic B12 deficiency, which is very common and usually missed, and patients with the T allele of MTHFR.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13574e257>Antiplatelet agents</h2><p class="" id=d13574e260>There are a couple of important developments in antiplatelet therapy. Grosser <i>et al</i>.<sup><a href="#ref-18">18</a></sup> reported that apparent “aspirin resistance” was due to enteric coating. We should probably be using chewable or uncoated aspirin, not coated aspirin.</p><p class="" id=d13574e270>The other major issue is that clopidogrel, a prodrug, requires activation by CYP2C19. Patients with a loss-of-function variant of CYP2C19 have reduced benefit of clopidogrel<sup><a href="#ref-19">19</a></sup>. That loss-of-function variant is present in ~30% of European and &gt;50% of Chinese patients. We probably should stop using clopidogrel and switch to prasugrel or ticlopidine. A recent study indicated that prasugrel was superior to ticlopidine<sup><a href="#ref-20">20</a></sup>.</p><p class="" id=d13574e281>There have been a number of other advances in antiplatelet therapy, including combination of aspirin with rivaroxaban, as well as dual antiplatelet therapy for the prevention of recurrent stroke, which are not discussed here owing to word count limits.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13574e287>Anticoagulants</h2><div class=section><a name=d13574e290 class=n-a></a><h3 class=section-title>Properties of direct-acting oral anticoagulants</h3><p class="" id=d13574e295>Although there are not randomized controlled trial (RCT) head-to-head comparisons across the class of direct-acting oral anticoagulants (DOACs), there are important differences in their pharmacokinetic properties that should be considered in choosing which one to use. These are summarized in <a href="#T1">Table 1</a><sup><a href="#ref-21">21</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Characteristics of direct-acting oral anticoagulants (DOACs).</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d13574e315 class=n-a></a><thead><a name=d13574e317 class=n-a></a><tr><a name=d13574e319 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d13574e321 class=n-a></a>Characteristic</th><th align=left colspan=1 rowspan=1><a name=d13574e324 class=n-a></a>Rivaroxaban</th><th align=left colspan=1 rowspan=1><a name=d13574e327 class=n-a></a>Dabigatran</th><th align=left colspan=1 rowspan=1><a name=d13574e330 class=n-a></a>Apixaban</th><th align=left colspan=1 rowspan=1><a name=d13574e333 class=n-a></a>Edoxaban</th></tr></thead><tbody><a name=d13574e338 class=n-a></a><tr><a name=d13574e340 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d13574e342 class=n-a></a>Target</td><td align=left colspan=1 rowspan=1><a name=d13574e345 class=n-a></a>Factor Xa</td><td align=left colspan=1 rowspan=1><a name=d13574e348 class=n-a></a>Factor IIa</td><td align=left colspan=1 rowspan=1><a name=d13574e351 class=n-a></a>Factor Xa</td><td align=left colspan=1 rowspan=1><a name=d13574e354 class=n-a></a>Factor Xa</td></tr><tr><a name=d13574e358 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d13574e360 class=n-a></a>Prodrug</td><td align=left colspan=1 rowspan=1><a name=d13574e363 class=n-a></a>No</td><td align=left colspan=1 rowspan=1><a name=d13574e366 class=n-a></a>Yes</td><td align=left colspan=1 rowspan=1><a name=d13574e369 class=n-a></a>No</td><td align=left colspan=1 rowspan=1><a name=d13574e372 class=n-a></a>No</td></tr><tr><a name=d13574e376 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d13574e378 class=n-a></a>Dosing</td><td align=left colspan=1 rowspan=1><a name=d13574e381 class=n-a></a>Once daily</td><td align=left colspan=1 rowspan=1><a name=d13574e384 class=n-a></a>Twice daily</td><td align=left colspan=1 rowspan=1><a name=d13574e387 class=n-a></a>Twice Daily</td><td align=left colspan=1 rowspan=1><a name=d13574e390 class=n-a></a>Once Daily</td></tr><tr><a name=d13574e394 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d13574e396 class=n-a></a>Bioavailability</td><td align=left colspan=1 rowspan=1><a name=d13574e399 class=n-a></a>80%–100%</td><td align=left colspan=1 rowspan=1><a name=d13574e402 class=n-a></a>6.5%</td><td align=left colspan=1 rowspan=1><a name=d13574e405 class=n-a></a>50%</td><td align=left colspan=1 rowspan=1><a name=d13574e408 class=n-a></a>62%</td></tr><tr><a name=d13574e412 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d13574e414 class=n-a></a>Half-life</td><td align=left colspan=1 rowspan=1><a name=d13574e417 class=n-a></a>5–13 hours</td><td align=left colspan=1 rowspan=1><a name=d13574e420 class=n-a></a>12–14 hours</td><td align=left colspan=1 rowspan=1><a name=d13574e423 class=n-a></a>8–15 hours</td><td align=left colspan=1 rowspan=1><a name=d13574e426 class=n-a></a>10–14 hours</td></tr><tr><a name=d13574e431 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d13574e433 class=n-a></a>Renal clearance </td><td align=left colspan=1 rowspan=1><a name=d13574e436 class=n-a></a>~33%</td><td align=left colspan=1 rowspan=1><a name=d13574e439 class=n-a></a>85%</td><td align=left colspan=1 rowspan=1><a name=d13574e442 class=n-a></a>~27%</td><td align=left colspan=1 rowspan=1><a name=d13574e445 class=n-a></a>~50%</td></tr><tr><a name=d13574e449 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d13574e451 class=n-a></a>Cmax</td><td align=left colspan=1 rowspan=1><a name=d13574e454 class=n-a></a>2–4 hours</td><td align=left colspan=1 rowspan=1><a name=d13574e457 class=n-a></a>1–2 hours</td><td align=left colspan=1 rowspan=1><a name=d13574e460 class=n-a></a>3–4 hours</td><td align=left colspan=1 rowspan=1><a name=d13574e463 class=n-a></a>1–2 hours</td></tr><tr><a name=d13574e467 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d13574e469 class=n-a></a>Interactions</td><td align=left colspan=1 rowspan=1><a name=d13574e472 class=n-a></a>Strong inhibitors of CYP3A4<br class=br>and P-gp</td><td align=left colspan=1 rowspan=1><a name=d13574e477 class=n-a></a>P-gp inhibitors</td><td align=left colspan=1 rowspan=1><a name=d13574e480 class=n-a></a>Strong inhibitors of<br class=br>CYP3A4 and P-gp</td><td align=left colspan=1 rowspan=1><a name=d13574e485 class=n-a></a>P-gp<br class=br>inhibitors</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d13574e495 class=n-a></a><p id=d13574e497> CYP3A4, intestinal cytochrome P450 3A4; P-gp, P-glycoprotein.</p></div><div class=footnote><a name=d13574e501 class=n-a></a><p id=d13574e503> This table was reproduced from Cardioembolic stroke: everything has changed, Spence JD, 3:76-83, 2018<sup><a href="#ref-21">21</a></sup> with permission from BMJ Publishing Group Ltd.</p></div></div></div><p class="" id=d13574e513>Dabigatran is the most renally excreted of the DOACs, so it is unsuitable for patients with impaired renal function. Since the mean eGFR in patients older than 80 is &lt;60 mL/minute/1.73 m<sup>2</sup><sup><a href="#ref-13">13</a></sup>, this means that dabigatran is probably not a good choice for elderly patients. Dabigatran also has by far the lowest bioavailability, which makes it subject to large changes in blood levels with small changes in absorption or with drug interactions. It has a narrow therapeutic range, so it has been suggested that blood levels of dabigatran should probably be monitored<sup><a href="#ref-22">22</a></sup>, thus negating one of the major advantages over warfarin. Rivaroxaban is not longer acting than the other DOACs, so it probably should not be administered once daily. Tellingly, recent studies with rivaroxaban have used twice-daily dosing<sup><a href="#ref-23">23</a></sup>. As edoxaban also does not have a half-life longer than that of other DOACs, it too should probably not be taken once daily.</p><p class="" id=d13574e530>Vriejens and Heidbuchel reviewed the advantages of twice-daily dosing with apixaban vs. once-daily dosing with rivaroxaban. With twice-daily dosing, the blood levels of the drug stay within the therapeutic range throughout the day, instead of swinging from too high to too low, and there is less impact of a missed dose or an extra dose. One missed dose of rivaroxaban would be equivalent to missing three doses of apixaban, and an extra dose of rivaroxaban has a much bigger effect, with risk of bleeding, than an extra dose of apixaban<sup><a href="#ref-24">24</a></sup> (<a href="#f1">Figure 1</a>).</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/25610/ec22d9e3-ce12-4854-8d1d-17e42864f33d_figure1.gif"><img alt="ec22d9e3-ce12-4854-8d1d-17e42864f33d_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/25610/ec22d9e3-ce12-4854-8d1d-17e42864f33d_figure1.gif"></a><div class=caption><h3>Figure 1. Once-daily vs. twice-daily dosing: difference between intake and predicted biological impact in general.</h3><p id=d13574e551>Different patterns of non-adherence lead to different exposition to “risk” between once-daily and twice-daily drugs. These graphs illustrate the theoretical pharmacokinetic proﬁles of a dose X administered once-daily (QD) and a dose X/2 administered twice-daily (BID) for a drug with a half-life of about 12 hours and a Tmax of 3 hours. (<b>A</b>) The peak-to-trough ratio is much smaller for the BID than the QD dosing. (<b>B</b>) The concentration after a single missed BID dose (red dot) is similar to the expected trough concentration of QD dosing, suggesting that missing a single dose of a twice-daily dosing regimen should not be therapeutically critical. (<b>C</b>) The pharmacological equivalent of missing a single dose in a once-daily regimen (blue dot) is missing three consecutive doses (red dots) of a twice-daily dosing regimen. (<b>D</b>) Taking an extra dose results in a much higher peak for the QD than for the BID dosing regimen. This figure was reproduced from Heidbuchel H, Vrijens B. Non-vitamin k antagonist oral anticoagulants: Considerations on once- vs. Twice-daily regimens and their potential impact on medication adherence. EP Europace. 2015;17:1317-1318<sup><a href="#ref-24">24</a></sup> by permission of Oxford University Press.</p></div></div><p class="" id=d13574e574>This may account for recent reports that apixaban is less likely to cause GI bleeding than rivaroxaban<sup><a href="#ref-25">25</a></sup>, more efficacious with regard to ischemic stroke or systemic embolism, and safer with regard to bleeding than rivaroxaban<sup><a href="#ref-26">26</a></sup>. In a study comparing risk of hip fracture among patients taking warfarin vs. DOACs, apixaban had the lowest risk of hip fracture<sup><a href="#ref-27">27</a></sup>.</p></div><div class=section><a name=d13574e590 class=n-a></a><h3 class=section-title>Misclassification of large artery atherosclerosis in embolic stroke of unknown source</h3><p class="" id=d13574e595>Antiplatelet agents are not anticoagulants; they prevent the aggregation of platelets in fast-flowing blood in arteries (white thrombus) but do not prevent “red thrombus”, which forms in the setting of stasis, with fibrin polymerization and entrapped red blood cells<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup>. For that reason, anticoagulants are more effective for preventing cardioembolic stroke.</p><p class="" id=d13574e605>In the past, when vitamin K antagonists such as warfarin were the only drugs available for anticoagulation, it was understandable that the paradigm would essentially be that one would never prescribe an anticoagulant without proving the presence of a cardioembolic source such as atrial fibrillation. However, since DOACs are not significantly more likely than aspirin to cause severe bleeding<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>, the paradigm should change. There are good reasons to think that in patients in whom a cardioembolic source is strongly suspected, it would be more prudent to prescribe a DOAC than an antiplatelet agent<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d13574e619>Several trials to test that hypothesis failed to show a benefit of anticoagulation in patients with embolic stroke of unknown source (ESUS); however, it is very likely that misclassification of large artery disease may have accounted for that. When large artery atherosclerosis (LAA) is defined as a 50% carotid stenosis, it will miss 79% of patients classified as LAA by a high carotid plaque burden<sup><a href="#ref-33">33</a></sup>. Since antiplatelet therapy is more efficacious in LAA, failing to exclude such patients may be why anticoagulation was not superior in ESUS. Importantly, a meta-analysis that was included in a substudy of one of those trials showed that anticoagulation was superior to antiplatelet therapy for patients with patent foramen ovale<sup><a href="#ref-34">34</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13574e634>Hypertension</h2><div class=section><a name=d13574e637 class=n-a></a><h3 class=section-title>Physiologically individualized therapy based on renin/aldosterone phenotyping</h3><p class="" id=d13574e642>Reasons why physiologically individualized therapy based on renin/aldosterone phenotyping significantly improves blood pressure control<sup><a href="#ref-35">35</a></sup>, discussed in the 2017 review, have become more apparent. The physiology of salt and water retention was reviewed in 2018<sup><a href="#ref-36">36</a></sup>. A study of hypertension in foreign-born vs. US-born blacks revealed that African-Americans have nearly twice the rate of hypertension<sup><a href="#ref-37">37</a></sup>, supporting the African Diaspora theory proposed by Grim<sup><a href="#ref-38">38</a></sup> and others: the very high mortality rate during the Atlantic crossing in slave ships, from diarrhea, vomiting, and sweating in the heat below decks, created a selective advantage for genetic causes of salt and water retention. It is now apparent that at least six genetic variants predispose to a primary aldosteronism/inappropriate aldosterone secretion phenotype (low renin/low aldosterone), best treated with an aldosterone antagonist such as spironolactone or eplerenone, and at least six predispose to a Liddle phenotype (low renin/low aldosterone), best treated with amiloride<sup><a href="#ref-39">39</a></sup>. An important cause of resistant hypertension is “Diagnostic Inertia” – failure to ask the question “What is the physiological driver of the hypertension in this patient?”. Plasma renin and aldosterone should be measured in a stimulated condition (i.e. while taking a diuretic, angiotensin receptor antagonist, or angiotensin-converting enzyme inhibitor), and the results should be interpreted in light of the class(es) of medication being taken at the time of blood sampling<sup><a href="#ref-40">40</a></sup>.</p></div><div class=section><a name=d13574e671 class=n-a></a><h3 class=section-title>Lower blood pressure targets in frail elderly patients</h3><p class="" id=d13574e676>In the wake of the Standard Trial of Intensive versus Blood-Pressure Control (SPRINT) trial, among participants with increased cardiovascular risk but without diabetes<sup><a href="#ref-41">41</a></sup>, lower blood pressure targets (a systolic pressure of &lt;120 mmHg) are being recommended for blood pressure control. This approach may be well suited to most hypertensive patients, but there is an important exception. Patients with stiff arteries are at risk from systolic targets that are too low. The reasons include 1. stiff arteries widen pulse pressure, 2. stiff arteries increase the likelihood that the blood pressure measured by a cuff is actually much higher than the true (intra-arterial) pressure<sup><a href="#ref-42">42</a></sup>, and 3. most of coronary perfusion<sup><a href="#ref-43">43</a></sup>, and more than half of cerebral perfusion<sup><a href="#ref-44">44</a></sup>, occurs during diastole. For that reason, patients with a diastolic pressure of &lt;60 mmHg with a pulse pressure of &gt;60 mmHg have a doubling of subclinical myocardial ischemia<sup><a href="#ref-43">43</a></sup> and a 5.85-fold increase in the risk of stroke<sup><a href="#ref-45">45</a></sup>. Frail elderly patients with stiff arteries (a pulse pressure of &gt;60 mmHg) should not be treated to a target systolic pressure of &lt;120 mmHg. A 2019 meta-analysis of standard vs. intensive blood pressure control for secondary stroke prevention supported a blood pressure target of less than 130/80 mmHg<sup><a href="#ref-46">46</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13574e713>Lipid-lowering therapy</h2><p class="" id=d13574e716>A key part of stroke prevention is lipid-lowering therapy; this is particularly important in patients with LAA. Amarenco <i>et al</i>. recently reported that lower target LDL-C significantly reduced the risk of recurrent stroke<sup><a href="#ref-47">47</a></sup>. Participants randomized to a lower target LDL-C of &lt;70 mg/dL (1.8 mmol/L) vs. a target range of 90 mg to 110 mg/dL (2.3 to 2.8 mmol/L) had a significantly lower risk of the primary endpoint (ischemic stroke, myocardial infarction, new symptoms leading to urgent coronary or carotid revascularization, or death from cardiovascular causes; adjusted hazard ratio [HR] 0.78; 95% confidence interval [CI] 0.61–0.98; <i>P</i> = 0.04). A frequently missed opportunity is in adding ezetimibe to statins; ezetimibe more than doubles the effect of statins, with fewer adverse effects than the use of high-dose statins<sup><a href="#ref-48">48</a></sup>. The recent European guidelines recommend the addition of ezetimibe in high-risk patients who do not achieve a target LDL-C of 140 mmol/L (53 mg/dL)<sup><a href="#ref-49">49</a></sup>. In the guideline, high risk was defined as having a previous cardiovascular event, but patients with asymptomatic carotid stenosis<sup><a href="#ref-50">50</a></sup>, a high coronary calcium score<sup><a href="#ref-51">51</a></sup>, or a high carotid plaque burden<sup><a href="#ref-52">52</a></sup> are also at very high risk<sup><a href="#ref-52">52</a></sup>. A number of new lipid-lowering therapies are in development<sup><a href="#ref-53">53</a></sup>.</p><p class="" id=d13574e758>Two other recent developments are from the 2019 European guideline on the management of dyslipidemia, with consensus guidelines recommending a lower target LDL-C of 1.4 mmol/L (53 mg/dL) and the use of ezetimibe in patients who do not achieve target levels with statin alone. Using ezetimibe with statins is an important measure. Because statins and ezetimibe work by different mechanisms, the combination is synergistic. Ezetimibe more than doubles the lowering of LDL-C by statins. In patients who do not tolerate full doses of statins, adding ezetimibe will achieve the effect of high-dose statins with fewer adverse effects (probably the only truly causal adverse effect of ezetimibe is loose bowel movements, rarely diarrhea).</p><p class="" id=d13574e761>The importance of keeping patients on their lipid-lowering therapy was shown in the 2020 trial by Amarenco <i>et al</i>.<sup><a href="#ref-47">47</a></sup>. Patients with ischemic stroke and atherosclerosis were randomized to a lower target LDL-C of less than 1.8 mmol/L (70 mg/dL) vs. a target of 2.3 to 2.8 mmol/L (90 mg to 110 mg/dL). At sites where patients were in the target range for &gt;50% of the time, major cardiovascular events were reduced by 36% (HR 0.64, 95% CI 0.48–0.85); at sites where participants were at target &lt;50% of the time, there was no reduction in major cardiovascular events (HR 1.14, 95% CI 0.75–1.73). There is a major problem with patients stopping statins for the wrong reasons (often influenced by internet nonsense). A review in 2016<sup><a href="#ref-48">48</a></sup> discussed approaches to helping patients stay on statins; adding ezetimibe is a cornerstone of that effort.</p><p class="" id=d13574e775>An important advance is that there is now good evidence that lipid-lowering therapy is even more beneficial in the elderly than in younger patients. I recently reviewed this issue<sup><a href="#ref-54">54</a></sup>. In the past, there was a tendency to withhold statins in older patients on the basis that since patients over the age of 80 years were not enrolled in randomized trials, there was no direct evidence of benefit; but, then again, there was also no evidence of harm! As discussed by Mortensen and Falk<sup><a href="#ref-55">55</a></sup>, because the elderly are at higher risk of cardiovascular events, the benefit of lipid lowering should be even greater in old patients than in younger patients, with a greater absolute risk reduction and a smaller number needed to treat (NNT). This has indeed been shown to be the case in an RCT of adding ezetimibe to simvastatin: the NNT in patients aged over 75 was only 11 vs. 125 in patients younger than 75. In an RCT in Japan, patients with a mean age of 80.6 years at baseline were randomized to diet alone or diet plus ezetimibe. Over a median follow-up of 4.1 years, there was a 34% reduction of composite cardiovascular events and a 40% reduction of combined coronary events<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d13574e791>A scientific statement from the American Heart Association in 2019 reviewed the evidence that statins do not cause most of the adverse effects that have been attributed to them<sup><a href="#ref-57">57</a></sup>. Collin <i>et al</i>. point out that most such putative adverse effects based on observational studies are the result of indication bias or confounders, and they are refuted by meta-analysis of randomized trials of statins in very large numbers of patients<sup><a href="#ref-58">58</a></sup>. The GREACE trial established that patients with elevated liver enzymes actually do better if they continue statins; “transaminitis” is probably due to fatty liver<sup><a href="#ref-59">59</a></sup>. The European Guideline<sup><a href="#ref-49">49</a></sup> now recommends against monitoring of liver function in patients on statins and against stopping statins on account of “transaminitis”. I recently reviewed the issue of intracerebral hemorrhage (ICH). The widespread belief that statins cause ICH was an artefact of an inappropriate intention-to-treat analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) RCT, in which ~25% of patients randomized to placebo crossed over to statin, and many patients randomized to statin stopped taking it. The proof that atorvastatin could not have caused ICH is that there was a greater reduction of ischemic stroke, but no increase in ICH, among SPARCL participants who achieved a 50% reduction of LDL-C (i.e. they were taking the medication)<sup><a href="#ref-60">60</a></sup>. Even if there were a slight increase in ICH with statins, there would be far greater harm from withholding or stopping statins than continuing them<sup><a href="#ref-61">61</a></sup>.</p><p class="" id=d13574e822>Lipid-lowering therapy should be intensive, should frequently (or usually) be combined with ezetimibe, and should not be withheld on account of age or misplaced fear of ICH. In some patients, if the very high cost is not an issue, therapies directed at proprotein convertase subtilisin/kexin type 9 (PCSK9) might be considered.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13574e828>Pioglitazone</h2><p class="" id=d13574e831>Diabetes and insulin resistance are risk factors for stroke. Pioglitazone, a weak agonist of peroxisome proliferator-activated receptor-α (PPAR-α) and a potent agonist of PPAR-γ, reduces insulin resistance and has anti-atherosclerotic effects<sup><a href="#ref-62">62</a></sup>. In 2016, the IRIS trial reported a 23% reduction in recurrent stroke with pioglitazone over 5 years in the intention-to-treat analysis, but adherence was suboptimal in many patients, mainly because of fluid retention and weight gain.</p><p class="" id=d13574e838>A meta-analysis in 2017 reported a 42% reduction of recurrent stroke with pioglitazone among patients with stroke and diabetes, insulin resistance, or prediabetes<sup><a href="#ref-63">63</a></sup>. In 2019, a substudy of the IRIS trial was conducted among participants with insulin resistance defined by a glycosylated hemoglobin (A1C) level of 5.7 to 6.4% or fasting plasma glucose level of 5.55 to 6.94 mmol/L (100mg/dL to 125mg/dL). Among those with good adherence (taking &gt;80% of the protocol dose), stroke or myocardial infarction was reduced by 43% in 5 years, recurrent stroke was reduced by 36%, and new-onset diabetes was reduced by 82%<sup><a href="#ref-62">62</a></sup> (<a href="#f2">Figure 2</a>).</p><a name=f2 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/25610/ec22d9e3-ce12-4854-8d1d-17e42864f33d_figure2.gif"><img alt="ec22d9e3-ce12-4854-8d1d-17e42864f33d_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/25610/ec22d9e3-ce12-4854-8d1d-17e42864f33d_figure2.gif"></a><div class=caption><h3>Figure 2. Effect of pioglitazone in patients with stroke and prediabetes: results in patients who took &gt;80% of the protocol dose.</h3><p id=d13574e862>(<b>A</b>) Stroke or myocardial infarction (hazard ratio [HR] 0.57; 95% confidence interval [CI] 0.39–0.84; <i>P</i> = 0.004). (<b>B</b>) Stroke (HR 0.64; 95% CI 0.42–0.99; <i>P</i> = 0.04). (<b>C</b>) Acute coronary syndrome (HR 0.47; 95% CI 0.26–0.85; <i>P</i> = 0.01). (<b>D</b>) Stroke/myocardial infarction (MI)/hospitalization for heart failure (HHF) (HR 0.61; 95% CI 0.42–0.88; <i>P</i> = 0.008). (<b>E</b>) New-onset diabetes (HR 0.18; 95% CI 0.10–0.33; <i>P</i> &lt;0.001). This figure was reproduced from Spence JD, Viscoli CM, Inzucchi SE, Dearborn-Tomazos J, Ford GA, Gorman M, <i>et al</i>. Pioglitazone therapy in patients with stroke and prediabetes: A post hoc analysis of the iris randomized clinical trial. JAMA Neurol. 2019;76:526-535<sup><a href="#ref-62">62</a></sup> with permission from the American Medical Association.</p></div></div><p class="" id=d13574e908>Pantoni, in an accompanying editorial<sup><a href="#ref-64">64</a></sup>, noted that pioglitazone is probably underutilized, in part because of a probably unjustified belief that it increases the risk of bladder cancer. There is also a risk of fractures with pioglitazone, but the NNT to prevent one stroke or myocardial infarction with pioglitazone is only 24, the NNT to prevent one case of new-onset diabetes is only 12, and the number needed to harm (NNH) to cause one serious fracture is 125<sup><a href="#ref-62">62</a></sup>. Pioglitazone should be used more widely for stroke prevention, both in diabetes and in prediabetes/metabolic syndrome.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13574e922>Carotid endarterectomy and stenting</h2><p class="" id=d13574e925>Recent advances include two important meta-analyses. Brott <i>et al</i>.<sup><a href="#ref-65">65</a></sup> reported from a pooled analysis of individual data from 4,754 participants in symptomatic carotid stenosis that CEA was superior to CAS; the risk of stroke or death or subsequent ipsilateral stroke with CEA was 2.8% (95% CI 1.1–4.4) vs. 4.1% (2.0–6.3) with CAS at follow-up times up to 10 years. These outcomes were dominated by periprocedural events<sup><a href="#ref-66">66</a></sup>. It is now clear from a meta-analysis by Howard <i>et al</i>.<sup><a href="#ref-67">67</a></sup> that CEA is preferable for most older patients (<a href="#f3">Figure 3</a>). “CAS should be reserved for selected patients. Factors that would favour CAS could include younger age, specific anatomical features (such as a stenosis that is in the very distal internal carotid artery), lack of tortuosity of the arteries leading to the stenosis, absence of or only minimal plaque calcification, presence of local tissue scarring due to previous surgery or radiation, and conditions conferring a high medical risk for surgery (such as congestive heart failure, myocardial ischaemia, or severe pulmonary disease)”<sup><a href="#ref-66">66</a></sup>.</p><a name=f3 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/25610/ec22d9e3-ce12-4854-8d1d-17e42864f33d_figure3.gif"><img alt="ec22d9e3-ce12-4854-8d1d-17e42864f33d_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/25610/ec22d9e3-ce12-4854-8d1d-17e42864f33d_figure3.gif"></a><div class=caption><h3>Figure 3. </h3><p class=first id=d13574e961>Estimated event rates for patients assigned to CEA (<b>A</b>) and CAS (<b>B</b>) by age stratum. The age groups are shown by the color key. Events plotted during the ﬁrst 120-day periprocedural period include stroke in either hemisphere plus deaths, whereas events during the postprocedural period include ipsilateral stroke only. Patients were censored at 6 years for the graphical presentation of event rates. CAS, carotid artery stenting; CEA, carotid endarterectomy. This figure was reprinted from The Lancet, 387, Howard G, Roubin GS, Jansen O, Hendrikse J, Halliday A, Fraedrich G, <i>et al</i>., Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: A meta-analysis of pooled patient data from four randomised trials, 1305-1311., 2016<sup><a href="#ref-67">67</a></sup> with permission from Elsevier.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d13574e984>Summary/conclusion</h2><p class="" id=d13574e987>What does the future hold? Probably advances in transcarotid stenting will show the benefit of this approach over transfemoral or transradial stenting. New therapies for cholesterol-lowering will probably also improve stroke prevention, as well as improvements in antiplatelet therapy. What questions remain? Ongoing RCTs of stenting vs. endarterectomy vs. intensive medical therapy will likely provide answers about asymptomatic stenosis that may be applicable to symptomatic carotid stenosis; also, we need further evidence about anticoagulation in ESUS when the misclassification of LAA has been addressed. There have been many recent advances in stroke prevention; no doubt more are to come.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d13574e994 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class=faculty-opinion-icon></span><span class="prime-red big">Faculty Opinions recommended</span></span><h2 class=main-title id=d13999>References</h2><div class="section ref-list"><a name=d13574e994 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d13574e1001 class=n-a></a>Spence JD: Recent advances in preventing stroke recurrence [version 1; peer review: 2 approved]. <i>F1000Res.</i> 2017; <b>6</b>: 1017. <a target=xrefwindow id=d13574e1009 href="http://www.ncbi.nlm.nih.gov/pubmed/28721209">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1012 href="https://doi.org/10.12688/f1000research.11597.1">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1015 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5497821">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d13574e1024 class=n-a></a>Epstein KA, Viscoli CM, Spence JD, <i> et al.</i>: Smoking cessation and outcome after ischemic stroke or TIA. <i>Neurology.</i> 2017; <b>89</b>(16): 1723–9. <a target=xrefwindow id=d13574e1035 href="http://www.ncbi.nlm.nih.gov/pubmed/28887378">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1038 href="https://doi.org/10.1212/WNL.0000000000004524">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1042 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5644463">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/734546844"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1051 class=n-a></a>Näslund U, Ng N, Lundgren A, <i> et al.</i>: Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): A pragmatic, open-label, randomised controlled trial. <i>Lancet.</i> 2019; <b>393</b>(10167): 133–42. <a target=xrefwindow id=d13574e1062 href="http://www.ncbi.nlm.nih.gov/pubmed/30522919">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1065 href="https://doi.org/10.1016/S0140-6736(18)32818-6">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/734546844">Faculty Opinions Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d13574e1078 class=n-a></a>Spence JD, Jenkins DJA, Davignon J: Dietary cholesterol and egg yolks: Not for patients at risk of vascular disease. <i> Can J Cardiol.</i> 2010; <b>26</b>(9): e336–e339. <a target=xrefwindow id=d13574e1086 href="http://www.ncbi.nlm.nih.gov/pubmed/21076725">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1089 href="https://doi.org/10.1016/s0828-282x(10)70456-6">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1092 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2989358">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d13574e1101 class=n-a></a>Spence JD, Jenkins D: Cardiovascular benefit of egg consumption is most unlikely. <i>Heart.</i> 2018; <b>104</b>(21): 1805–6. <a target=xrefwindow id=d13574e1109 href="http://www.ncbi.nlm.nih.gov/pubmed/30309867">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1112 href="https://doi.org/10.1136/heartjnl-2018-313687">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d13574e1122 class=n-a></a>Mozaffarian D, Benjamin EJ, Go AS, <i> et al.</i>: Heart disease and stroke statistics--2015 update: a report from the American Heart Association. <i>Circulation.</i> 2015; <b>131</b>(4): e29–322. <a target=xrefwindow id=d13574e1133 href="http://www.ncbi.nlm.nih.gov/pubmed/25520374">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1136 href="https://doi.org/10.1161/CIR.0000000000000152">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d13574e1145 class=n-a></a>Trichopoulou A, Psaltopoulou T, Orfanos P, <i> et al.</i>: Diet and physical activity in relation to overall mortality amongst adult diabetics in a general population cohort. <i>J Intern Med.</i> 2006; <b>259</b>(6): 583–91. <a target=xrefwindow id=d13574e1156 href="http://www.ncbi.nlm.nih.gov/pubmed/16704559">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1159 href="https://doi.org/10.1111/j.1365-2796.2006.01638.x">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/718454843"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1168 class=n-a></a>Tang WHW, Wang Z, Levison BS, <i> et al.</i>: Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. <i>N Engl J Med.</i> 2013; <b>368</b>(17): 1575–84. <a target=xrefwindow id=d13574e1179 href="http://www.ncbi.nlm.nih.gov/pubmed/23614584">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1182 href="https://doi.org/10.1056/NEJMoa1109400">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1186 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3701945">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/718454843">Faculty Opinions Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d13574e1199 class=n-a></a>Bogiatzi C, Gloor G, Allen-Vercoe E, <i> et al.</i>: Metabolic products of the intestinal microbiome and extremes of atherosclerosis. <i>Atherosclerosis.</i> 2018; <b>273</b>: 91–7. <a target=xrefwindow id=d13574e1210 href="http://www.ncbi.nlm.nih.gov/pubmed/29702430">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1213 href="https://doi.org/10.1016/j.atherosclerosis.2018.04.015">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/737501035"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1222 class=n-a></a>Nemet I, Saha PP, Gupta N, <i> et al.</i>: A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. <i>Cell.</i> 2020; <b>180</b>(5): 862–877.e22. <a target=xrefwindow id=d13574e1233 href="http://www.ncbi.nlm.nih.gov/pubmed/32142679">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1236 href="https://doi.org/10.1016/j.cell.2020.02.016">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1240 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7402401">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/737501035">Faculty Opinions Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735327068"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1253 class=n-a></a>Zhong VW, van Horn L, Cornelis MC, <i> et al.</i>: Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality. <i>JAMA.</i> 2019; <b>321</b>(11): 1081–1095. <a target=xrefwindow id=d13574e1264 href="http://www.ncbi.nlm.nih.gov/pubmed/30874756">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1267 href="https://doi.org/10.1001/jama.2019.1572">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1271 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6439941">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735327068">Faculty Opinions Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d13574e1285 class=n-a></a>Pignanelli M, Bogiatzi C, Gloor G, <i> et al.</i>: Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications. <i>J Ren Nutr.</i> 2019; <b>29</b>(1): 55–64. <a target=xrefwindow id=d13574e1296 href="http://www.ncbi.nlm.nih.gov/pubmed/30100156">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1299 href="https://doi.org/10.1053/j.jrn.2018.05.007">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d13574e1308 class=n-a></a>Spence JD, Urquhart BL, Bang H: Effect of renal impairment on atherosclerosis: Only partially mediated by homocysteine. <i>Nephrol Dial Transplant.</i> 2016; <b>31</b>(6): 937–44. <a target=xrefwindow id=d13574e1316 href="http://www.ncbi.nlm.nih.gov/pubmed/26567910">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1319 href="https://doi.org/10.1093/ndt/gfv380">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1322 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4876968">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d13574e1331 class=n-a></a>Spence JD, Yi Q, Hankey GJ: B vitamins in stroke prevention: Time to reconsider. <i> Lancet Neurol.</i> 2017; <b>16</b>(9): 750–60. <a target=xrefwindow id=d13574e1339 href="http://www.ncbi.nlm.nih.gov/pubmed/28816120">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1342 href="https://doi.org/10.1016/S1474-4422(17)30180-1">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d13574e1351 class=n-a></a>Qin X, Spence JD, Li J, <i> et al.</i>: Interaction of serum vitamin B<sub>12</sub> and folate with <i>MTHFR</i> genotypes on risk of ischemic stroke. <i>Neurology.</i> 2020; <b>94</b>(11): e1126–e1136. <a target=xrefwindow id=d13574e1369 href="http://www.ncbi.nlm.nih.gov/pubmed/31932513">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1372 href="https://doi.org/10.1212/WNL.0000000000008932">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1375 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7220236">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d13574e1384 class=n-a></a>McNulty H, Le Dowey RC, Strain JJ, <i> et al.</i>: Riboflavin Lowers Homocysteine in Individuals Homozygous for the <i>MTHFR</i> 677C→T Polymorphism. <i>Circulation.</i> 2006; <b>113</b>(1): 74–80. <a target=xrefwindow id=d13574e1398 href="http://www.ncbi.nlm.nih.gov/pubmed/16380544">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1402 href="https://doi.org/10.1161/CIRCULATIONAHA.105.580332">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d13574e1411 class=n-a></a>McNulty H, Strain JJ, Hughes CF, <i> et al.</i>: Riboflavin, <i>MTHFR</i> genotype and blood pressure: A personalized approach to prevention and treatment of hypertension. <i>Mol Aspects Med.</i> 2017; <b>53</b>: 2–9. <a target=xrefwindow id=d13574e1425 href="http://www.ncbi.nlm.nih.gov/pubmed/27720779">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1429 href="https://doi.org/10.1016/j.mam.2016.10.002">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/717969219"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1439 class=n-a></a>Grosser T, Fries S, Lawson JA, <i> et al.</i>: Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin. <i>Circulation.</i> 2013; <b>127</b>(3): 377–85. <a target=xrefwindow id=d13574e1450 href="http://www.ncbi.nlm.nih.gov/pubmed/23212718">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1453 href="https://doi.org/10.1161/CIRCULATIONAHA.112.117283">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1457 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3552520">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/717969219">Faculty Opinions Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d13574e1470 class=n-a></a>Wang Y, Zhao X, Lin J, <i> et al.</i>: Association Between <i>CYP2C19</i> Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack. <i>JAMA.</i> 2016; <b>316</b>(1): 70–8. <a target=xrefwindow id=d13574e1484 href="http://www.ncbi.nlm.nih.gov/pubmed/27348249">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1488 href="https://doi.org/10.1001/jama.2016.8662">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736524631"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1497 class=n-a></a> Schüpke S, Neumann F, Menichelli M, <i> et al.</i>: Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. <i> N Engl J Med.</i> 2019; <b>381</b>(16): 1524–1534. <a target=xrefwindow id=d13574e1508 href="http://www.ncbi.nlm.nih.gov/pubmed/31475799">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1511 href="https://doi.org/10.1056/NEJMoa1908973">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736524631">Faculty Opinions Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d13574e1524 class=n-a></a>Spence JD: Cardioembolic stroke: Everything has changed. <i>Stroke Vasc Neurol.</i> 2018; <b>3</b>(2): 76–83. <a target=xrefwindow id=d13574e1532 href="http://www.ncbi.nlm.nih.gov/pubmed/30022801">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1535 href="https://doi.org/10.1136/svn-2018-000143">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1538 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6047338">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/718122898"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1547 class=n-a></a>Reilly PA, Lehr T, Haertter S, <i> et al.</i>: The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). <i>J Am Coll Cardiol.</i> 2014; <b>63</b>(4): 321–8. <a target=xrefwindow id=d13574e1558 href="http://www.ncbi.nlm.nih.gov/pubmed/24076487">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1561 href="https://doi.org/10.1016/j.jacc.2013.07.104">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/718122898">Faculty Opinions Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d13574e1574 class=n-a></a>Anand SS, Bosch J, Eikelboom JW, <i> et al.</i>: Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: An international, randomised, double-blind, placebo-controlled trial. <i>Lancet.</i> 2018; <b>391</b>(10117): 219–29. <a target=xrefwindow id=d13574e1585 href="http://www.ncbi.nlm.nih.gov/pubmed/29132880">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1588 href="https://doi.org/10.1016/S0140-6736(17)32409-1">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d13574e1598 class=n-a></a>Heidbuchel H, Vrijens B: Non-vitamin K antagonist oral anticoagulants (NOAC): Considerations on once- vs. twice-daily regimens and their potential impact on medication adherence. <i>Europace.</i> 2015; <b>17</b>(8): 1317–8. <a target=xrefwindow id=d13574e1606 href="http://www.ncbi.nlm.nih.gov/pubmed/26045506">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1609 href="https://doi.org/10.1093/europace/euv124">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d13574e1618 class=n-a></a>Abraham NS, Noseworthy PA, Yao X, <i> et al.</i>: Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study. <i>Gastroenterology.</i> 2017; <b>152</b>(5): 1014–1022.e1. <a target=xrefwindow id=d13574e1629 href="http://www.ncbi.nlm.nih.gov/pubmed/28043907">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1632 href="https://doi.org/10.1053/j.gastro.2016.12.018">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/737511771"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1641 class=n-a></a>Fralick M, Colacci M, Schneeweiss S, <i> et al.</i>: Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice: A Cohort Study. <i>Ann Intern Med.</i> 2020; <b>172</b>(7): 463–73. <a target=xrefwindow id=d13574e1652 href="http://www.ncbi.nlm.nih.gov/pubmed/32150751">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1655 href="https://doi.org/10.7326/M19-2522">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/737511771">Faculty Opinions Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736984739"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1668 class=n-a></a>Lutsey PL, Norby FL, Ensrud KE, <i> et al.</i>: Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation. <i>JAMA Intern Med.</i> 2020; <b>180</b>(2): 245–253. <a target=xrefwindow id=d13574e1679 href="http://www.ncbi.nlm.nih.gov/pubmed/31764956">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1682 href="https://doi.org/10.1001/jamainternmed.2019.5679">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1686 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6902159">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736984739">Faculty Opinions Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d13574e1699 class=n-a></a>Deykin D: Thrombogenesis. <i>N Engl J Med.</i> 1967; <b>276</b>(11): 622–8. <a target=xrefwindow id=d13574e1707 href="http://www.ncbi.nlm.nih.gov/pubmed/6018451">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1710 href="https://doi.org/10.1056/NEJM196703162761107">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d13574e1719 class=n-a></a>Caplan LR, Fisher M: The endothelium, platelets, and brain ischemia. <i>Rev Neurol Dis.</i> 2007; <b>4</b>(3): 113–21. <a target=xrefwindow id=d13574e1727 href="http://www.ncbi.nlm.nih.gov/pubmed/17943063">PubMed Abstract </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/9310957"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1737 class=n-a></a>Connolly SJ, Eikelboom J, Joyner C, <i> et al.</i>: Apixaban in Patients with Atrial Fibrillation. <i>N Engl J Med.</i> 2011; <b>364</b>(9): 806–17. <a target=xrefwindow id=d13574e1748 href="http://www.ncbi.nlm.nih.gov/pubmed/21309657">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1751 href="https://doi.org/10.1056/NEJMoa1007432">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/9310957">Faculty Opinions Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/727423286"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1764 class=n-a></a>Weitz JI, Lensing AWA, Prins MH, <i> et al.</i>: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. <i>N Engl J Med.</i> 2017; <b>376</b>(13): 1211–22. <a target=xrefwindow id=d13574e1775 href="http://www.ncbi.nlm.nih.gov/pubmed/28316279">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1778 href="https://doi.org/10.1056/NEJMoa1700518">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/727423286">Faculty Opinions Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d13574e1791 class=n-a></a>Spence JD: Anticoagulation in patients with Embolic Stroke of Unknown Source. <i>Int J Stroke.</i> 2019; <b>14</b>(4): 334–6. <a target=xrefwindow id=d13574e1799 href="http://www.ncbi.nlm.nih.gov/pubmed/30644794">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1802 href="https://doi.org/10.1177/1747493019826363">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d13574e1811 class=n-a></a>Bogiatzi C, Wannarong T, McLeod AI, <i> et al.</i>: SPARKLE (Subtypes of Ischaemic Stroke Classification System), Incorporating Measurement of Carotid Plaque Burden: A New Validated Tool for the Classification of Ischemic Stroke Subtypes. <i>Neuroepidemiology.</i> 2014; <b>42</b>(4): 243–51. <a target=xrefwindow id=d13574e1822 href="http://www.ncbi.nlm.nih.gov/pubmed/24862944">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1825 href="https://doi.org/10.1159/000362417">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d13574e1834 class=n-a></a>Kasner SE, Swaminathan B, Lavados P, <i> et al.</i>: Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: A prespecified subgroup analysis from the NAVIGATE ESUS trial. <i>Lancet Neurol.</i> 2018; <b>17</b>(12): 1053–60. <a target=xrefwindow id=d13574e1845 href="http://www.ncbi.nlm.nih.gov/pubmed/30274772">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1848 href="https://doi.org/10.1016/S1474-4422(18)30319-3">Publisher Full Text </a> | <a target=xrefwindow id=d13574e1852 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6662613">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d13574e1861 class=n-a></a>Akintunde A, Nondi J, Gogo K, <i> et al.</i>: Physiological Phenotyping for Personalized Therapy of Uncontrolled Hypertension in Africa. <i>Am J Hypertens.</i> 2017; <b>30</b>(9): 923–30. <a target=xrefwindow id=d13574e1872 href="http://www.ncbi.nlm.nih.gov/pubmed/28472315">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1875 href="https://doi.org/10.1093/ajh/hpx066">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d13574e1885 class=n-a></a>Spence JD, Rayner BL: Hypertension in Blacks: Individualized Therapy Based on Renin/Aldosterone Phenotyping. <i>Hypertension.</i> 2018; <b>72</b>(2): 263–9. <a target=xrefwindow id=d13574e1893 href="http://www.ncbi.nlm.nih.gov/pubmed/29941519">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1896 href="https://doi.org/10.1161/HYPERTENSIONAHA.118.11064">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d13574e1905 class=n-a></a>Spence JD: Hypertension in US-born vs. foreign-born African-Americans. <i>J Hypertens.</i> 2017; <b>35</b>(12): 2369–71. <a target=xrefwindow id=d13574e1913 href="http://www.ncbi.nlm.nih.gov/pubmed/29095228">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1916 href="https://doi.org/10.1097/HJH.0000000000001501">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d13574e1925 class=n-a></a>Grim CE, Robinson M: Salt, slavery and survival- hypertension in the African diaspora. <i>Epidemiology.</i> 2003; <b>14</b>(1): 120–2. <a target=xrefwindow id=d13574e1933 href="http://www.ncbi.nlm.nih.gov/pubmed/12500061">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1936 href="https://doi.org/10.1097/00001648-200301000-00029">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d13574e1945 class=n-a></a>Spence JD: Hypertension in Africa. <i>Eur J Prev Cardiol.</i> 2019; <b>26</b>(5): 455–7. <a target=xrefwindow id=d13574e1953 href="http://www.ncbi.nlm.nih.gov/pubmed/30595049">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1956 href="https://doi.org/10.1177/2047487318823575">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d13574e1965 class=n-a></a>Huang X, Li J, Liu L, <i> et al.</i>: Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: Importance of the class of stimulating drugs. <i>Hypertens Res.</i> 2019; <b>42</b>(12): 1971–1978. <a target=xrefwindow id=d13574e1976 href="http://www.ncbi.nlm.nih.gov/pubmed/31562418">PubMed Abstract </a> | <a target=xrefwindow id=d13574e1979 href="https://doi.org/10.1038/s41440-019-0327-2">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/725924077"><span class="faculty-opinion-icon small"></span></a><a name=d13574e1988 class=n-a></a>SPRINT Research Group,Wright JT, Williamson JD, Whelton PK, <i> et al.</i>: A Randomized Trial of Intensive versus Standard Blood-Pressure Control. <i>N Engl J Med.</i> 2015; <b>373</b>(22): 2103–16. <a target=xrefwindow id=d13574e1999 href="http://www.ncbi.nlm.nih.gov/pubmed/26551272">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2002 href="https://doi.org/10.1056/NEJMoa1511939">Publisher Full Text </a> | <a target=xrefwindow id=d13574e2006 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4689591">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/725924077">Faculty Opinions Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d13574e2020 class=n-a></a>Finnegan TP, Spence JD, Wong DG, <i> et al.</i>: Blood pressure measurement in the elderly: Correlation of arterial stiffness with difference between intra-arterial and cuff pressures. <i>J Hypertens.</i> 1985; <b>3</b>(3): 231–5. <a target=xrefwindow id=d13574e2031 href="http://www.ncbi.nlm.nih.gov/pubmed/4020129">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2034 href="https://doi.org/10.1097/00004872-198506000-00006">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/726708894"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2043 class=n-a></a>McEvoy JW, Chen Y, Rawlings A, <i> et al.</i>: Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control. <i>J Am Coll Cardiol.</i> 2016; <b>68</b>(16): 1713–22. <a target=xrefwindow id=d13574e2054 href="http://www.ncbi.nlm.nih.gov/pubmed/27590090">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2057 href="https://doi.org/10.1016/j.jacc.2016.07.754">Publisher Full Text </a> | <a target=xrefwindow id=d13574e2061 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5089057">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/726708894">Faculty Opinions Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d13574e2074 class=n-a></a>Spence JD: Spectral analysis of carotid vs femoral doppler velocity patterns: A clue to genesis of flow disturbances in cerebral arteries. <i>Frontiers of Engineering in Health Care.</i> 1981; 0000–0355. </span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d13574e2086 class=n-a></a>Park JH, Ovbiagele B: Post-stroke diastolic blood pressure and risk of recurrent vascular events. <i>Eur J Neurol.</i> 2017; <b>24</b>(11): 1416–23. <a target=xrefwindow id=d13574e2094 href="http://www.ncbi.nlm.nih.gov/pubmed/28940906">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2097 href="https://doi.org/10.1111/ene.13411">Publisher Full Text </a> | <a target=xrefwindow id=d13574e2100 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5657577">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736286688"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2109 class=n-a></a>Kitagawa K, Yamamoto Y, Arima H, <i> et al.</i>: Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke: A Randomized Clinical Trial and Meta-analysis. <i>JAMA Neurol.</i> 2019; <b>76</b>(11): 1309. <a target=xrefwindow id=d13574e2120 href="http://www.ncbi.nlm.nih.gov/pubmed/31355878">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2123 href="https://doi.org/10.1001/jamaneurol.2019.2167">Publisher Full Text </a> | <a target=xrefwindow id=d13574e2127 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6664380">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736286688">Faculty Opinions Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736924813"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2140 class=n-a></a>Amarenco P, Kim JS, Labreuche J, <i> et al.</i>: A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke. <i>N Engl J Med.</i> 2020; <b>382</b>(1): 9. <a target=xrefwindow id=d13574e2151 href="http://www.ncbi.nlm.nih.gov/pubmed/31738483">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2154 href="https://doi.org/10.1056/NEJMoa1910355">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736924813">Faculty Opinions Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d13574e2168 class=n-a></a>Spence JD, Dresser GK: Overcoming Challenges With Statin Therapy. <i>J Am Heart Assoc.</i> 2016; <b>5</b>(1): e002497. <a target=xrefwindow id=d13574e2176 href="http://www.ncbi.nlm.nih.gov/pubmed/26819251">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2179 href="https://doi.org/10.1161/JAHA.115.002497">Publisher Full Text </a> | <a target=xrefwindow id=d13574e2182 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4859367">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d13574e2191 class=n-a></a>Mach F, Baigent C, Catapano AL, <i> et al.</i>: 2019 esc/eas guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The task force for the management of dyslipidaemias of the european society of cardiology (esc) and european atherosclerosis society (eas). <i>Eur Heart J.</i> 2019. </span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d13574e2206 class=n-a></a>Chimowitz MI, Weiss DG, Cohen SL, <i> et al.</i>: Cardiac prognosis of patients with carotid stenosis and no history of coronary artery disease. Veterans Affairs Cooperative Study Group 167. <i>Stroke.</i> 1994; <b>25</b>(4): 759–65. <a target=xrefwindow id=d13574e2217 href="http://www.ncbi.nlm.nih.gov/pubmed/8160217">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2220 href="https://doi.org/10.1161/01.str.25.4.759">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/733682825"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2229 class=n-a></a>Greenland P, Blaha MJ, Budoff MJ, <i> et al.</i>: Coronary Calcium Score and Cardiovascular Risk. <i>J Am Coll Cardiol.</i> 2018; <b>72</b>(4): 434–47. <a target=xrefwindow id=d13574e2240 href="https://doi.org/10.1016/j.jacc.2018.05.027">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/733682825">Faculty Opinions Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d13574e2253 class=n-a></a>Spence JD, Eliasziw M, DiCicco M, <i> et al.</i>: Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. <i>Stroke.</i> 2002; <b>33</b>(12): 2916–22. <a target=xrefwindow id=d13574e2264 href="http://www.ncbi.nlm.nih.gov/pubmed/12468791">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2267 href="https://doi.org/10.1161/01.str.0000042207.16156.b9">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/734959155"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2276 class=n-a></a>Hegele RA, Tsimikas S: Lipid-Lowering Agents. <i>Circ Res.</i> 2019; <b>124</b>: 386–404. <a target=xrefwindow id=d13574e2284 href="https://emedicine.medscape.com/article/2172172-overview">Reference Source</a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/734959155">Faculty Opinions Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d13574e2298 class=n-a></a>Spence JD: The need for clinical judgement in the application of evidence-based medicine. <i>BMJ EBM.</i> 2019; bmjebm-2019-111300. <a target=xrefwindow id=d13574e2303 href="http://www.ncbi.nlm.nih.gov/pubmed/31806620">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2306 href="https://doi.org/10.1136/bmjebm-2019-111300">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/732404757"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2315 class=n-a></a>Mortensen MB, Falk E: Primary Prevention With Statins in the Elderly. <i>J Am Coll Cardiol.</i> 2018; <b>71</b>(1): 85–94. <a target=xrefwindow id=d13574e2323 href="http://www.ncbi.nlm.nih.gov/pubmed/29301631">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2326 href="https://doi.org/10.1016/j.jacc.2017.10.080">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/732404757">Faculty Opinions Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/736478606"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2339 class=n-a></a>Ouchi Y, Sasaki J, Arai H, <i> et al.</i>: Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial. <i>Circulation.</i> 2019; <b>140</b>(12): 992–1003. <a target=xrefwindow id=d13574e2350 href="http://www.ncbi.nlm.nih.gov/pubmed/31434507">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2353 href="https://doi.org/10.1161/CIRCULATIONAHA.118.039415">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/736478606">Faculty Opinions Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/734683567"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2366 class=n-a></a>Newman CB, Preiss D, Tobert JA, <i> et al.</i>: Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. <i>Arterioscler Thromb Vasc Biol.</i> 2019; <b>39</b>(2): e38–e81. <a target=xrefwindow id=d13574e2377 href="http://www.ncbi.nlm.nih.gov/pubmed/30580575">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2380 href="https://doi.org/10.1161/ATV.0000000000000073">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/734683567">Faculty Opinions Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/726731676"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2393 class=n-a></a>Collins R, Reith C, Emberson J, <i> et al.</i>: Interpretation of the evidence for the efficacy and safety of statin therapy. <i>Lancet.</i> 2016; <b>388</b>(10059): 2532–61. <a target=xrefwindow id=d13574e2404 href="http://www.ncbi.nlm.nih.gov/pubmed/27616593">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2407 href="https://doi.org/10.1016/S0140-6736(16)31357-5">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/726731676">Faculty Opinions Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/6701956"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2420 class=n-a></a>Athyros VG, Tziomalos K, Gossios TD, <i> et al.</i>: Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis. <i>Lancet.</i> 2010; <b>376</b>(9756): 1916–22. <a target=xrefwindow id=d13574e2431 href="http://www.ncbi.nlm.nih.gov/pubmed/21109302">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2434 href="https://doi.org/10.1016/S0140-6736(10)61272-X">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/6701956">Faculty Opinions Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d13574e2448 class=n-a></a>Amarenco P, Goldstein LB, Szarek M, <i> et al.</i>: Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. <i>Stroke.</i> 2007; <b>38</b>(12): 3198–204. <a target=xrefwindow id=d13574e2459 href="http://www.ncbi.nlm.nih.gov/pubmed/17962589">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2462 href="https://doi.org/10.1161/STROKEAHA.107.493106">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735361392"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2471 class=n-a></a>Judge C, Ruttledge S, Costello M, <i> et al.</i>: Lipid Lowering Therapy, Low-Density Lipoprotein Level and Risk of Intracerebral Hemorrhage – A Meta-Analysis. <i>J Stroke Cerebrovasc Dis.</i> 2019; <b>28</b>(6): 1703–9. <a target=xrefwindow id=d13574e2482 href="http://www.ncbi.nlm.nih.gov/pubmed/30878368">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2485 href="https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.02.018">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735361392">Faculty Opinions Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d13574e2498 class=n-a></a>Spence JD, Viscoli CM, Inzucchi SE, <i> et al.</i>: Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial. <i>JAMA Neurol.</i> 2019; <b>76</b>(5): 526–35. <a target=xrefwindow id=d13574e2509 href="http://www.ncbi.nlm.nih.gov/pubmed/30734043">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2512 href="https://doi.org/10.1001/jamaneurol.2019.0079">Publisher Full Text </a> | <a target=xrefwindow id=d13574e2516 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6515584">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/727132716"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2525 class=n-a></a>Lee M, Saver JL, Liao HW, <i> et al.</i>: Pioglitazone for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis. <i>Stroke.</i> 2017; <b>48</b>(2): 388–93. <a target=xrefwindow id=d13574e2536 href="http://www.ncbi.nlm.nih.gov/pubmed/27999139">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2539 href="https://doi.org/10.1161/STROKEAHA.116.013977">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/727132716">Faculty Opinions Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735125914"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2552 class=n-a></a>Pantoni L: Potential New Horizons for the Prevention of Cerebrovascular Diseases and Dementia. <i>JAMA Neurol.</i> 2019; <b>76</b>(5): 521–2. <a target=xrefwindow id=d13574e2560 href="http://www.ncbi.nlm.nih.gov/pubmed/30734044">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2563 href="https://doi.org/10.1001/jamaneurol.2018.4406">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735125914">Faculty Opinions Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/735063286"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2576 class=n-a></a>Brott TG, Calvet D, Howard G, <i> et al.</i>: Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: A preplanned pooled analysis of individual patient data. <i>Lancet Neurology.</i> 2019; <b>18</b>(4): 348–56. <a target=xrefwindow id=d13574e2587 href="http://www.ncbi.nlm.nih.gov/pubmed/30738706">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2590 href="https://doi.org/10.1016/S1474-4422(19)30028-6">Publisher Full Text </a> | <a target=xrefwindow id=d13574e2594 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6773606">Free Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/735063286">Faculty Opinions Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d13574e2608 class=n-a></a>Spence JD: Periprocedural events dominate outcomes of carotid stenting and endarterectomy. <i> Lancet Neurol.</i> 2019; <b>18</b>(4): 321–2. <a target=xrefwindow id=d13574e2616 href="http://www.ncbi.nlm.nih.gov/pubmed/30738707">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2619 href="https://doi.org/10.1016/S1474-4422(19)30040-7">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="Faculty Opinions recommended" class="research-layout prime-recommended-reference" href="https://facultyopinions.com/prime/726151715"><span class="faculty-opinion-icon small"></span></a><a name=d13574e2628 class=n-a></a>Howard G, Roubin GS, Jansen O, <i> et al.</i>: Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: A meta-analysis of pooled patient data from four randomised trials. <i>Lancet.</i> 2016; <b>387</b>(10025): 1305–11. <a target=xrefwindow id=d13574e2639 href="http://www.ncbi.nlm.nih.gov/pubmed/26880122">PubMed Abstract </a> | <a target=xrefwindow id=d13574e2642 href="https://doi.org/10.1016/S0140-6736(15)01309-4">Publisher Full Text </a> | <a target=_blank title="Faculty Opinions recommended" href="https://facultyopinions.com/prime/726151715">Faculty Opinions Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Aug 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-1012&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-1012&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Western University, and Stroke Prevention &amp; Atherosclerosis Research Centre, Robarts Research Institute, Ontario, Canada<br/> <p> <div class=margin-bottom> J David Spence <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-1012/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 20 Aug 2020, 9:1012 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.23199.1">https://doi.org/10.12688/f1000research.23199.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Spence JD. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=25610 data-id=23199 data-downloads="" data-views="" data-scholar="10.12688/f1000research.23199.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-1012/v1/pdf?article_uuid=142923ee-cc57-4df1-91ac-3d2e15092dca" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.23199.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Spence JD. Recent advances in preventing recurrent stroke [version 1; peer review: 3 approved] <i>F1000Research</i> 2020, <b>9</b>(Faculty Rev):1012 (<a href="https://doi.org/10.12688/f1000research.23199.1" target=_blank>https://doi.org/10.12688/f1000research.23199.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=23199 id=mobile-track-article-signin-23199 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/23199?target=/articles/9-1012"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=25610 /> <input name=articleId type=hidden value=23199 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Amytis Towfighi</strong>, Division of Stroke and Neurocritical Care, Department of Neurology, University of Southern California, Los Angeles, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Georgios Tsivgoulis</strong>, Second Department of Neurology, National and Kapodistrian University of Athens, Greece </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Craig S. Anderson</strong>, George Institute for Global Health, University of New South Wales, Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Aug 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-1012&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-1012&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=74894-69930></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=74893-69931></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23944-69929></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-1012/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>20 Aug 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Amytis Towfighi</strong>, Division of Stroke and Neurocritical Care, Department of Neurology, University of Southern California, Los Angeles, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Georgios Tsivgoulis</strong>, Second Department of Neurology, National and Kapodistrian University of Athens, Greece </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Craig S. Anderson</strong>, George Institute for Global Health, University of New South Wales, Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-1012&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-1012/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in preventing recurrent stroke".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-1012/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-1012/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-1012/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Spence JD');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-1012/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-1012",
            templates : {
                twitter : "Recent advances in preventing recurrent stroke. Spence JD, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-1012/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in preventing recurrent stroke", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in preventing recurrent stroke", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/23199/25610")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "25610");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "69929": 1,
                           "69931": 1,
                           "69930": 6,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "d988bae8-651e-4360-8a88-ba751c109968";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-1012.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-1012.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-1012.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-1012.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-1012.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>